• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry

tetano

Editor, Senior Moderator
Anal Bioanal Chem. 2013 Jun 11. [Epub ahead of print]
Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry.
Swaminathan K, Dyason JC, Maggioni A, von Itzstein M, Downard KM.
Source

School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia.
Abstract

The binding of a natural anthocyanin to influenza neuraminidase has been studied employing mass spectrometry and molecular docking. Derived from a black elderberry extract, cyanidin-3-sambubiocide has been found to be a potent inhibitor of sialidase activity. This study reveals the molecular basis for its activity for the first time. The anthocyanin is shown by parallel experimental and computational approaches to bind in the so-called 430-cavity in the vicinity of neuraminidase residues 356-364 and 395-432. Since this antiviral compound binds remote from Asp 151 and Glu 119, two residues known to regulate neuraminidase resistance, it provides the potential for the development of a new class of antivirals against the influenza virus without this susceptibility.

PMID:
23748498
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23748498
 
Back
Top Bottom